EFFECT OF PENTOXIFYLLINE ON ISCHEMIC ACUTE RENAL FAILURE IN RABBITS

REFERENCES

• Diamond J R, Pesek I. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Lab Invest 1991; 64: 21–28
   PubMed Web of Science ®Google Scholar
• Egido J, Gomez C M, Ortiz A, Bustos C, Alonso J, Gomez G C, Gomez G D, Lopez A M, Plaza J, Gonzalez E. Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. Kidney Int 1993; 39: S59–S64
   Google Scholar
• Tipping P G, Leong T W, Holdsworth S R. Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest 1991; 65: 272–279
   PubMed Web of Science ®Google Scholar
• Mulligan M S, Johnson K J, Todd R F, Issekutz T B, Miyasaka M, Tamatani T, Smith C W, Anderson D C, Ward P A. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 1993; 91: 577–587
   PubMed Web of Science ®Google Scholar
• Navarro J F, Mora C, Rivero A, Gallego E, Chahin J, Macia M, Mendez M L, Garcia J. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration. Am J Kidney Dis 1999; 33: 458–463
   PubMed Web of Science ®Google Scholar
• Baud L, Ardaillou R. Tumor necrosis factor alpha in glomerular injury. Kidney Int 1994; Suppl 45: S32–S36
   Google Scholar
• Myers B D, Moran S M. Hemodynamically mediated acute renal failure. N Eng J Med 1986; 314: 97–105
   PubMed Web of Science ®Google Scholar
• Gillings D B. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses. J Cardiovasc Pharmacol 25 1995; Supp l2: 544–550
   Google Scholar
• Staudinger T, Presterl E, Graninger W, Locker G J, Knapp S, Laczika K, Klappacher G, Stoiser B, Wagner A, Tesinsky P, Kordova H, Frass M. Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock. Intensive Care Med 1996; 22: 888–893
   PubMed Web of Science ®Google Scholar
• Strieter R M, Remick D G, Ward P A, Spengler R N, Lynch J P, Larrick J, Kunkel S L. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988; 155: 1230–1236
   PubMed Web of Science ®Google Scholar
• Kim Y K, Lee S H, Goldinger J M, Hong S K. Effect of ethanol on organic ion transport in rabbit kidney. Toxicol Appl Pharmacol 1986; 86: 411–420
   PubMed Web of Science ®Google Scholar
• Fiske C H, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66: 375–400
   Google Scholar
• Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 6: 271–278
   Google Scholar
• Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Kim Y K, Woo J S, Kim Y H, Jung J S, Kim B S, Lee S H. Effect of renal ischaemia on organic compound transport in rabbit kidney proximal tubule. Pharmacol Toxicol 1995; 77: 121–129
   PubMedGoogle Scholar
• Ciuffetti G, Mercuri M, Ott C, Lombardini R, Paltriccia R, Lupattelli G, Santambrogio L, Mannarino E. Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study. Eur J Clin Pharmacol 1991; 41: 511–515
   PubMed Web of Science ®Google Scholar
• Franzini E, Sellak H, Hakim J, Pasquier C. Oxidative damage to lysozyme by the hydroxyl radical: comparative effects of scavengers. Biochim Biophys Acta 1993; 1203: 11–17
   PubMed Web of Science ®Google Scholar
• Hostetter T H, Brenner B M. Renal circulatory and nephron function in experimental acute renal failure. Acute Renal Failure, B M Brenner, J M Lazarus. Churchill Livingstone, New York 1988; 67–90
   Google Scholar
• Franklin W A, Ganote C E, Jennings R B. Blood reflow after renal ischemia. Effects of hypertonic mannitol on reflow and tubular necrosis after transient ischemia in the rat. Arch Pathol 1974; 98: 106–111
   PubMedGoogle Scholar
• Zager R A. Alterations of intravascular volume: influence on renal susceptibility to ischemic injury. J Lab Clin Med 1986; 108: 60–69
   PubMed Web of Science ®Google Scholar
• Mason J, Welsch J, Torhorst J. The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int 1987; 31: 65–71
   PubMed Web of Science ®Google Scholar
• Sinzinger H. Pentoxifylline enhances formation of prostacyclin from rat vascular and renal tissue. Prostaglandins Leukot Med 1983; 12: 217–226
   PubMedGoogle Scholar
• Vadiei K, Brunner L J, Luke D R. Effects of pentoxifylline in experimental acute renal failure. Kidney Int 1989; 36: 466–470
   PubMed Web of Science ®Google Scholar
• Jackson E K. Renal actions of purines. Purinergic approaches in experimental therapeutics, K A Jackson, M F Jarvis. John Wiley & Sons, New York 1997; 217–250
   Google Scholar
• Lewis R M, Rice J H, Patton M K, Barnes J L, Nickel A E, Osgood RW, Fried T, Stein J H. Renal ischemic injury in the dog: characterization and effect of various pharmacologic agents. J Lab Clin Med 1984; 104: 470–479
   PubMedGoogle Scholar
• Vilcek J, Lee T H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991; 266: 7313–7316
   PubMed Web of Science ®Google Scholar
• Donnahoo K K, Shames B D, Harken A H, Meldrum D R. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Uro 1999; 162: 196–203
   PubMed Web of Science ®Google Scholar
• Colletti L M, Remick D G, Burtch G D, Kunkel S L, Strieter R M, Campbell-DA J. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936–1943
   PubMed Web of Science ®Google Scholar
• Taylor C T, Fueki N, Agah A, Hershberg R M, Colgan S P. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-alpha. J Biol Chem 1999; 274: 19447–19454
   Google Scholar
• Loftis L L, Meals E A, English B K. Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J Infect Dis 1997; 175: 1008–1011
   PubMed Web of Science ®Google Scholar
• Kim S Y, Kim C H, Yoo H J, Kim Y K. Effects of radical scavengers and antioxidant on ischemic acute renal failure in rabbits. Renal Failure 1999; 21: 1–11
   Web of Science ®Google Scholar
• Gamelin L M, Zager R A. Evidence against oxidant injury as a critical mediator of postischemic acute renal failure. Am J Physiol 1988; 255: F450–F460
   PubMed Web of Science ®Google Scholar
• Borkan S C, Schwartz J H. Role of oxygen free radical species in in vitro models of proximal tubular ischemia. Am J Physiol 1989; 57: F114–F125
   Google Scholar
• Johnston P A, Rennke H, Levinsky N G. Recovery of proximal tubular function from ischemic injury. Am J Physiol 1984; 246: F159–F166
   Google Scholar
• Molitoris B A, Kinne R. Ischemia induces surface membrane dysfunction. Mechanism of altered Na+-dependent glucose transport. J Clin Invest 1987; 80: 647–654
   PubMed Web of Science ®Google Scholar
• Ullrich K J. Driving forces for the transport of organic solutes. Renal transport of organic substances, R Greger, F Lang, S Silbernagl. Springer-Verlag, Berlin/Heidelberg/New York 1981; 17–29
   Google Scholar